SEC 13F Intelligence

Endurant Capital Management LP / ABBV

Endurant Capital Management LP’s Abbvie Inc Position

Does Endurant Capital Management LP own Abbvie Inc (ABBV)? Not currently — the last reported position was 180.4K shares worth $19M in Q3 2021; the fund’s latest 13F (Q1 2024) no longer reports it.

Position Value
$19M
Q3 2021
Shares
180.4K
% of Portfolio
+4.43%
Quarters Held
10
position exited

Position History ABBV

Reported value by quarter
Q1 ’19: $2MQ1 ’19Q2 ’19: $6MQ3 ’19: $12MQ3 ’19Q4 ’19: $9MQ2 ’20: $6MQ2 ’20Q3 ’20: $17MQ4 ’20: $9MQ4 ’20Q1 ’21: $10MQ2 ’21: $10MQ2 ’21Q3 ’21: $19Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 2021180.4K$19M+4.43%
Q2 202185.5K$10M+2.65%
Q1 202188.0K$10M+2.48%
Q4 202084.5K$9M+3.27%
Q3 2020198.9K$17M+5.15%
Q2 202062.6K$6M+0.34%
Q4 201998.6K$9M+2.75%
Q3 2019162.0K$12M+4.40%
Q2 201989.0K$6M+2.55%
Q1 201921.7K$2M+0.69%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Endurant Capital Management LP’s full portfolio or all institutional holders of ABBV.